INDOCYANINE GREEN for SELECTIVE SENTINELLA AXILLARY LYMPH NODE BIOPSY in PATIENTS with BREAST CANCER
Status: Recruiting
Location: See location...
Intervention Type: Other, Drug
Study Type: Observational
SUMMARY
The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: f
View:
• Patients \>18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
• N0 patients or patients who have undergone target axillary detection with good response
Locations
Other Locations
Spain
Sandra Lopez Gordo
RECRUITING
Cerdanyola Del Vallès
Contact Information
Primary
Sandra Lopez gordo
sandra.lopezgordo@gmail.com
0034660284047
Backup
Sandra Lopez gordo
sandra.lopezgordo@gmail.com
660284047
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2029-01-01
Participants
Target number of participants: 15000
Related Therapeutic Areas
Sponsors
Leads: Omphis Foundation